Bio-Techne
TECH
#1989
Rank
$9.61 B
Marketcap
$61.68
Share price
-2.93%
Change (1 day)
-16.16%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

EPS for Bio-Techne (TECH)

EPS in 2025 (TTM): $0.50

According to Bio-Techne's latest financial reports the company's current EPS (TTM) is $0.50. In 2024 the company made an earnings per share (EPS) of $1.00 a decrease over its 2023 EPS that were of $1.42.

EPS history for Bio-Techne from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)$0.50-50%
2024$1.00-29.58%
2023$1.42-14.97%
2022$1.6724.16%
2021$1.3417.98%
2020$1.14-10.94%
2019$1.28101.57%
2018$0.64-16.99%
2017$0.7645.02%
2016$0.53-20.97%
2015$0.67-14.97%
2014$0.78

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
$17.34 3,368.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
-$24.31-4,962.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
$5.57 1,014.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
$4.88 876.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
$1.87 273.74%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
General Electric
GE
$7.56 1,412.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-$0.21-142.00%๐Ÿ‡บ๐Ÿ‡ธ USA